Skip to main content

DTI-100: Studies to support IND filing and alternative delivery methods

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Dec 3, 2014
Award amount: 
$250,000
Organization name: 
Dignify Therapeutics, LLC
Principal Investigator: 
Burgard, Edward
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Region: 
Research Triangle

Dignify Therapeutics is developing DTI-100, a novel compound for the treatment of bladder and bowel disorders in people with spinal injuries. This SRL will support studies of the safety profile of DTI-100 and will help develop a final formulation of DTI-100 for use in clinical trials.

Fiscal year: 
2015